Commentary

The House just passed a controversial SBIR reauthorization bill with the usual shenanigans by Rep. Nydia Velazquez (D-NY). As in last year's reauthorization debacle, Ms Velazquez completely stifled any testimony contrary to her preferences. The major point of contention is whether to allow companies that...

For candidates seeking employment at a job fair, an initial interview with a company may last only five minutes. While a job seeker has to be qualified in order to get the job, there will always be several other people who are equally qualified as...

Viewing profiles? Capturing recent information? Tracking communications? Building lists? Predicting activities? The Customer Relationship Management (CRM), processes a company uses to track and organize its contacts with its current and prospective customers are a one-way road on the social media landscape....

According to a report in FierceBiotech, surprising news came out of the recently completed 45th Annual Meeting of the Drug Information Association (DIA). Despite cutbacks in the international biopharma industry, clinical trial activity was up in 2008. Overall, 795 new clinical trials were launched...

As China has continued to grow as a major contender in the world economy, the Chinese have become more aware of the need to strengthen their system for intellectual property rights (IPR). Chinese patent law was first promulgated in 1984 and soon thereafter China became...

Clinical trials can be vexing, just ask anyone associated with Osiris Therapeutics, a leading stem cell therapeutic company. The company recently announced that their mid-stage, Phase II trials to treat chronic obstructive pulmonary disease (COPD) with adult stem cells (called Prochymal) did a great job...

Clinical trials can be vexing, just ask anyone associated with Osiris Therapeutics, a leading stem cell therapeutic company. The company recently announced that their mid-stage, Phase II trials to treat chronic obstructive pulmonary disease (COPD) with adult stem cells (called Prochymal) did a great job...